{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:11:19Z","timestamp":1790424679723,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Introduction\n<\/jats:title>\n                <jats:p>At the time of diagnosis, 15\u201320% of gastric carcinomas are in stage T4 or T4b. Furthermore, 5\u201320% of patients undergoing potentially curative surgery suffer from synchronous or metachronous peritoneal metastases. To date, neither surgery nor systemic chemotherapy successfully controls peritoneal dissemination, offering a limited impact on survival. Peritoneal metastases are in fact responsible for death in around 60% of gastric cancer patients.<\/jats:p>\n                <jats:p>Several Eastern studies in the past have focused on hyperthermic intraperitoneal chemotherapy (HIPEC) as a prophylactic measure in patients with serosal extension, nodal involvement, and positive peritoneal fluid cytology. Therefore, a new multimodal therapeutic strategy based on aggressive surgery plus new locoregional treatment may prolong survival in this particular clinical scenario.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study compares the efficacy of prophylactic surgery (radical gastric resection, appendectomy, resection of the round ligament of the liver, and bilateral adnexectomy) plus hybrid CO2 HIPEC system versus standard surgery in patients with T3-T4 N0-N\u2009+\u2009gastric adenocarcinoma. Patients will be randomly assigned (1:1 ratio) to the experimental arm or standard surgery. The primary endpoint is to establish the difference in disease-free survival between the groups. The secondary objective is to compare the safety and tolerability of prophylactic surgery plus HIPEC CO<jats:sub>2<\/jats:sub> versus standard surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Considering the poor prognosis of patients with peritoneal dissemination from gastric cancer, a prophylactic strategy to prevent peritoneal metastases may be beneficial. In patients with gastric cancer at high risk of peritoneal carcinomatosis, we propose aggressive surgical treatment with radical gastrectomy, removal of organs at risk of harbouring tumour cells, and HIPEC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT03917173. Registered on 16 April 2019.<\/jats:p>\n                <jats:p>Protocol version: v1, March 27, 2019.<\/jats:p>\n                <jats:p>Protocol number: IRFMN-GCC-7813.<\/jats:p>\n                <jats:p>EudraCT number: 2019\u2013001478-27.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06880-y","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:23:45Z","timestamp":1669919025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)\u2014a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO"],"prefix":"10.1186","volume":"23","author":[{"given":"A.","family":"Di Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-3815","authenticated-orcid":false,"given":"C.","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bonavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Torri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Santullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Garattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Rulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GOETH Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"6880_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"issue":"6","key":"6880_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.gie.2011.01.030","volume":"73","author":"S Mocellin","year":"2011","unstructured":"Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73(6):1122\u201334. https:\/\/doi.org\/10.1016\/j.gie.2011.01.030 (Epub 2011 Mar 27 PMID: 21444080).","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"6880_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/SLA.0000000000002040","volume":"267","author":"JH Lee","year":"2018","unstructured":"Lee JH, Chang KK, Yoon C, Tang LH, Strong VE, Yoon SS. Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma. Ann Surg. 2018;267(1):105\u201313. https:\/\/doi.org\/10.1097\/SLA.0000000000002040 (PMID:27759618;PMCID:PMC5515689).","journal-title":"Ann Surg"},{"issue":"9","key":"6880_CR4","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1245\/s10434-017-5838-y","volume":"24","author":"N Ikoma","year":"2017","unstructured":"Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD. Patterns of initial recurrence in gastric adenocarcinoma in the era of preoperative therapy. Ann Surg Oncol. 2017;24(9):2679\u201387. https:\/\/doi.org\/10.1245\/s10434-017-5838-y (Epub 2017 Mar 22 PMID: 28332034).","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"6880_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","volume":"40","author":"F Coccolini","year":"2014","unstructured":"Coccolini F, Cotte E, Glehen O, Lotti M, Poiasina E, Catena F, Yonemura Y, Ansaloni L. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol. 2014;40(1):12\u201326. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.019.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"6880_CR6","first-page":"379","volume":"23","author":"DP Kelsen","year":"1996","unstructured":"Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol. 1996;23(3):379\u201389 (PMID: 8658222).","journal-title":"Semin Oncol"},{"key":"6880_CR7","doi-asserted-by":"publisher","unstructured":"Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993;72(1):37\u201341. https:\/\/doi.org\/10.1002\/1097-0142(19930701)72:1%3c37::aid-cncr2820720109%3e3.0.co;2-p (PMID: 8508427).","DOI":"10.1002\/1097-0142(19930701)72:1%3c37::aid-cncr2820720109%3e3.0.co;2-p"},{"issue":"3","key":"6880_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/bjc.1995.114","volume":"71","author":"S Pyrh\u00f6nen","year":"1995","unstructured":"Pyrh\u00f6nen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71(3):587\u201391. https:\/\/doi.org\/10.1038\/bjc.1995.114 (PMID:7533517;PMCID:PMC2033628).","journal-title":"Br J Cancer"},{"key":"6880_CR9","volume-title":"Palliative chemotherapy versus supportive care in patients with metastatic gastric cancer: a randomized trial. Second International Conference on Biology, Prevention and Treatment of GI Malignancy, Koln","author":"W Scheithauer","year":"1995","unstructured":"Scheithauer W. Palliative chemotherapy versus supportive care in patients with metastatic gastric cancer: a randomized trial. Second International Conference on Biology, Prevention and Treatment of GI Malignancy, Koln. Germany: Second International Conference on Biology; 1995."},{"issue":"2","key":"6880_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1023\/a:1008243606668","volume":"8","author":"B Glimelius","year":"1997","unstructured":"Glimelius B, Ekstr\u00f6m K, Hoffman K, Graf W, Sj\u00f6d\u00e9n PO, Haglund U, Svensson C, Enander LK, Linn\u00e9 T, Sellstr\u00f6m H, Heuman R. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8(2):163\u20138. https:\/\/doi.org\/10.1023\/a:1008243606668 (PMID: 9093725).","journal-title":"Ann Oncol"},{"issue":"12","key":"6880_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ejso.2010.09.006","volume":"36","author":"Y Yonemura","year":"2010","unstructured":"Yonemura Y, Endou Y, Sasaki T, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Li Y. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol. 2010;36(12):1131\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2010.09.006 (Epub 2010 Oct 8 PMID: 20933363).","journal-title":"Eur J Surg Oncol"},{"issue":"suppl 5","key":"6880_CR12","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38\u201349. https:\/\/doi.org\/10.1093\/annonc\/mdw350 (PMID: 27664260).","journal-title":"Ann Oncol."},{"issue":"7","key":"6880_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, Gebski V, Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681\u201392. https:\/\/doi.org\/10.1016\/S1470-2045(11)70142-5 (Epub 2011 Jun 16. PMID: 21684205).","journal-title":"Lancet Oncol."},{"issue":"2","key":"6880_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jso.24476","volume":"115","author":"PL Feingold","year":"2017","unstructured":"Feingold PL, Kwong ML, Davis JL, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: a systematic review. J Surg Oncol. 2017;115(2):192\u2013201. https:\/\/doi.org\/10.1002\/jso.24476 (Epub 2016 Nov 23 PMID: 27878811).","journal-title":"J Surg Oncol"},{"issue":"9","key":"6880_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ejso.2016.03.035","volume":"42","author":"F Coccolini","year":"2016","unstructured":"Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Ceresoli M, Montori G, Ansaloni L. Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis. Eur J Surg Oncol. 2016;42(9):1261\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2016.03.035 (Epub 2016 Apr 19. PMID: 27134147).","journal-title":"Eur J Surg Oncol."},{"issue":"14","key":"6880_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2407-14-183","volume":"14","author":"O Glehen","year":"2014","unstructured":"Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G, Piaton E, Garofalo A. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer. 2014;14(14):183. https:\/\/doi.org\/10.1186\/1471-2407-14-183 (PMID:24628950; PMCID:PMC3995601).","journal-title":"BMC Cancer"},{"key":"6880_CR17","doi-asserted-by":"publisher","unstructured":"Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61(2):232\u20137. https:\/\/doi.org\/10.1002\/1097-0142(19880115)61:2%3c232::aid-cncr2820610205%3e3.0.co;2-u (PMID: 3121165).","DOI":"10.1002\/1097-0142(19880115)61:2%3c232::aid-cncr2820610205%3e3.0.co;2-u"},{"key":"6880_CR18","doi-asserted-by":"publisher","unstructured":"Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer. 1994;73(8):2048\u201352. https:\/\/doi.org\/10.1002\/1097-0142(19940415)73:8%3c2048::aid-cncr2820730806%3e3.0.co;2-q (PMID: 8156509).","DOI":"10.1002\/1097-0142(19940415)73:8%3c2048::aid-cncr2820730806%3e3.0.co;2-q"},{"issue":"3","key":"6880_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","volume":"85","author":"S Fujimoto","year":"1999","unstructured":"Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85(3):529\u201334 (PMID: 10091726).","journal-title":"Cancer"},{"issue":"3","key":"6880_CR20","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF00299188","volume":"19","author":"Y Yonemura","year":"1995","unstructured":"Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 1995;19(3):450\u20134. https:\/\/doi.org\/10.1007\/BF00299188 (PMID: 7639005 discussion 455).","journal-title":"World J Surg."},{"issue":"1","key":"6880_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00348209","volume":"18","author":"T Fujimura","year":"1994","unstructured":"Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H, Ninomiya I, Matsumoto H, Tsugawa K, Nishimura G, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study. World J Surg. 1994;18(1):150\u20135.","journal-title":"World J Surg."},{"issue":"42","key":"6880_CR22","first-page":"1776","volume":"48","author":"Y Yonemura","year":"2001","unstructured":"Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, Sugiyama K, Kawamura T, Kinoshita K, Endou Y, Sasaki T. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology. 2001;48(42):1776\u201382 (PMID: 11813623).","journal-title":"Hepatogastroenterology."},{"key":"6880_CR23","unstructured":"WHO.\u00a0The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. 2020. ISBN: 978 92 4 001029 1."},{"issue":"6497","key":"6880_CR24","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1126\/science.abd3377","volume":"368","author":"NE Sharpless","year":"2020","unstructured":"Sharpless NE. COVID-19 and cancer. Science. 2020;368(6497):1290. https:\/\/doi.org\/10.1126\/science.abd3377 (PMID: 32554570).","journal-title":"Science"},{"key":"6880_CR25","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1200\/GO.20.00220","volume":"6","author":"A Smrke","year":"2020","unstructured":"Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E, Macklin-Doherty A, Cojocaru E, Arthur A, Benson C, Miah AB, Zaidi S, Gennatas S, Jones RL. Telemedicine during the COVID-19 pandemic: impact on care for rare cancers. JCO Glob Oncol. 2020;6:1046\u201351. https:\/\/doi.org\/10.1200\/GO.20.00220 (PMID:32639877;PMCID:PMC7392777).","journal-title":"JCO Glob Oncol"},{"issue":"3","key":"6880_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, Beane JD, Steinberg SM, Beresnev T, Webb CC, Walker M, Toomey MA, Schrump D, Pandalai P, Stojadinovic A, Avital I. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275\u201384. https:\/\/doi.org\/10.1002\/jso.23633 (Epub 2014 Jul 5).","journal-title":"J Surg Oncol."},{"issue":"4","key":"6880_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.surg.2013.12.005","volume":"155","author":"S S\u00e1nchez-Garc\u00eda","year":"2014","unstructured":"S\u00e1nchez-Garc\u00eda S, Padilla-Valverde D, Villarejo-Campos P, Mart\u00edn-Fern\u00e1ndez J, Garc\u00eda-Rojo M, Rodr\u00edguez-Mart\u00ednez M. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system. Surgery. 2014;155(4):719\u201325. https:\/\/doi.org\/10.1016\/j.surg.2013.12.005 (Epub 2013 Dec 14. PMID: 24502804).","journal-title":"Surgery."},{"issue":"5","key":"6880_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/02656736.2016.1152515","volume":"32","author":"S S\u00e1nchez-Garc\u00eda","year":"2016","unstructured":"S\u00e1nchez-Garc\u00eda S, Villarejo-Campos P, Padilla-Valverde D, Amo-Salas M, Mart\u00edn-Fern\u00e1ndez J. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-10 Combat): a clinical pilot study. Int J Hyperthermia. 2016;32(5):488\u201395. https:\/\/doi.org\/10.3109\/02656736.2016.1152515 (Epub 2016 Apr 7. PMID: 27056558).","journal-title":"Int J Hyperthermia."},{"issue":"4","key":"6880_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13304-018-0557-x","volume":"70","author":"S Cianci","year":"2018","unstructured":"Cianci S, Vizzielli G, Fagotti A, Pacelli F, Di Giorgio A, Tropea A, Biondi A, Scambia G. A novel HIPEC technique using hybrid CO2 recirculation system: intra-abdominal diffusion test in a porcine model. Updates Surg. 2018;70(4):529\u201333. https:\/\/doi.org\/10.1007\/s13304-018-0557-x (Epub 2018 Jun 25 PMID: 29943156).","journal-title":"Updates Surg"},{"issue":"3","key":"6880_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s13304-018-0578-5","volume":"71","author":"S Cianci","year":"2019","unstructured":"Cianci S, Abatini C, Fagotti A, Chiofalo B, Tropea A, Biondi A, Scambia G, Pacelli F. Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO2 system: preliminary experience in referral center. Updates Surg. 2019;71(3):555\u201360. https:\/\/doi.org\/10.1007\/s13304-018-0578-5 (Epub 2018 Aug 9 PMID: 30094567).","journal-title":"Updates Surg"},{"key":"6880_CR31","first-page":"1","volume":"29","author":"S Rotolo","year":"2021","unstructured":"Rotolo S, Di Giorgio A, Santullo F, El Halabieh MA, Lodoli C, Abatini C, Pacelli F. Cytoreductive surgery and mitomycin C hyperthermic intraperitoneal chemotherapy with CO 2 recirculation (HIPEC-CO 2) for colorectal cancer peritoneal metastases: analysis of short-term outcomes. Updat Surg. 2021;29:1\u20136.","journal-title":"Updat Surg"},{"key":"6880_CR32","doi-asserted-by":"publisher","first-page":"141585","DOI":"10.1155\/2012\/141585","volume":"2012","author":"P Sammartino","year":"2012","unstructured":"Sammartino P, Sibio S, Biacchi D, Cardi M, Accarpio F, Mingazzini P, Rosati MS, Cornali T, Di Giorgio A. Prevention of peritoneal metastases from colon cancer in high-risk patients: preliminary results of surgery plus prophylactic HIPEC. Gastroenterol Res Pract. 2012;2012:141585. https:\/\/doi.org\/10.1155\/2012\/141585 (Epub 2012 May 8. PMID: 22645605; PMCID: PMC3356888).","journal-title":"Gastroenterol Res Pract."},{"issue":"9","key":"6880_CR33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00384-014-1929-4","volume":"29","author":"P Sammartino","year":"2014","unstructured":"Sammartino P, Sibio S, Biacchi D, Cardi M, Mingazzini P, Rosati MS, Cornali T, Sollazzo B, Atta JM, Di Giorgio A. Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. Int J Colorectal Dis. 2014;29(9):1081\u20139. https:\/\/doi.org\/10.1007\/s00384-014-1929-4 (Epub 2014 Jul 1 PMID: 24980687).","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"6880_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00268-015-3326-8","volume":"40","author":"F Rosa","year":"2016","unstructured":"Rosa F, Marrelli D, Morgagni P, Cipollari C, Vittimberga G, Framarini M, Cozzaglio L, Pedrazzani C, Berardi S, Baiocchi GL, Roviello F, Portolani N, de Manzoni G, Costamagna G, Doglietto GB, Pacelli F. Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter Western experience. World J Surg. 2016;40(4):921\u20138. https:\/\/doi.org\/10.1007\/s00268-015-3326-8 (PMID: 26552908).","journal-title":"World J Surg"},{"issue":"12","key":"6880_CR35","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.ejso.2019.07.030","volume":"45","author":"MY Reutovich","year":"2019","unstructured":"Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. Eur J Surg Oncol. 2019;45(12):2405\u201311. https:\/\/doi.org\/10.1016\/j.ejso.2019.07.030 (Epub 2019 Jul 31 PMID: 31387756).","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"6880_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/1471-2407-12-526","volume":"16","author":"J Sun","year":"2012","unstructured":"Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, Liang J, Xu H. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;16(12):526. https:\/\/doi.org\/10.1186\/1471-2407-12-526 (PMID:23153379;PMCID:PMC3551633).","journal-title":"BMC Cancer"},{"key":"6880_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","volume":"79","author":"J Desiderio","year":"2017","unstructured":"Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, Parisi A, Woo Y. The 30-year experience-a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017;79:1\u201314. https:\/\/doi.org\/10.1016\/j.ejca.2017.03.030.","journal-title":"Eur J Cancer."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06880-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06880-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06880-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:24:47Z","timestamp":1669919087000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06880-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6880"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06880-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"969"}}